Isavuconazole treatment of a patient with disseminated mucormycosis.
about
Role of isavuconazole in the treatment of invasive fungal infectionsIsavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendationsEmerging issues with diagnosis and management of fungal infections in solid organ transplant recipientsIsavuconazole: A New Option for the Management of Invasive Fungal Infections.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.Isavuconazole: a new extended spectrum triazole for invasive mold diseases.Isavuconazole as salvage therapy for mucormycosis.Successful Treatment of Primary Cutaneous Mucormycosis Complicating Anti-TNF Therapy with a Combination of Surgical Debridement and Oral Posaconazole.Comparison of the EUCAST and CLSI Broth Microdilution Methods for Testing Isavuconazole, Posaconazole, and Amphotericin B against Molecularly Identified Mucorales Species.Tissue Distribution and Elimination of Isavuconazole following Single and Repeat Oral-Dose Administration of Isavuconazonium Sulfate to Rats.Cutaneous mucormycosis.Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.Isavuconazole: A Promising Salvage Therapy for Invasive Mucormycosis.
P2860
Q26740837-41370BBF-B522-4980-85F0-19F1EF6D3B2BQ28067726-B328B9DB-D06B-4F98-BAC0-663AA12DE4B9Q28084643-56B297F8-407F-43F0-8CE8-098D314D98D3Q34474946-D12646CA-7FE2-4FDC-AEAD-47FB5362C536Q37041199-84593499-F6BE-4E7E-A801-CD0C801B868FQ38285488-76B6F54A-6D1B-45B7-9D79-0829105FB654Q38644817-56403753-1FEB-44AD-B76C-970D237B071DQ38866474-CEEBBF17-BAC1-4436-9A53-D5BC2EA888CFQ38939506-9D00AE39-4E3F-4B07-A1CB-8FA44FB0FF3FQ39003715-BDF99FCA-B414-417A-A7B9-E5C1DA44B98AQ40637005-F8BD3363-50BC-4CA8-BF6E-60FB1FE695E7Q40795565-4326E5DB-AD18-45C5-B3A7-D21CF6725436Q40965373-A3A0555B-EAB2-4BD9-9431-6A275840764BQ47151374-61B0E58C-788E-4134-ADA1-C36946BF5DE6Q49510166-6DA61063-4FF5-4245-9875-FB1780561FA1Q54214603-1B7875B0-73E7-453A-A560-045C48273997Q55363363-9B135E66-0131-4EAF-ACE6-A6468852DDFC
P2860
Isavuconazole treatment of a patient with disseminated mucormycosis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Isavuconazole treatment of a patient with disseminated mucormycosis.
@en
type
label
Isavuconazole treatment of a patient with disseminated mucormycosis.
@en
prefLabel
Isavuconazole treatment of a patient with disseminated mucormycosis.
@en
P2093
P2860
P356
P1476
Isavuconazole treatment of a patient with disseminated mucormycosis.
@en
P2093
Amy C Joyce
Driele Peixoto
Erin T Gilmore
Lisa S Gagne
Robert J Soiffer
P2860
P304
P356
10.1128/JCM.03176-13
P407
P577
2014-01-08T00:00:00Z